Ignite Creation Date:
2025-12-24 @ 3:50 PM
Ignite Modification Date:
2026-03-09 @ 4:09 AM
Study NCT ID:
NCT02433392
Status:
TERMINATED
Last Update Posted:
2021-04-21
First Post:
2015-04-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Intraparenchymal Therapy as Adjunct Therapy in Patients With Recurrent, Resectable Glioblastoma Multiforme.
Sponsor:
Boston Scientific Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CA1021
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |